Status:
COMPLETED
The Effect of Fetal Heartbeat Monitoring on Prenatal Attachment and Partner Adjustment
Lead Sponsor:
Kahramanmaras Sutcu Imam University
Conditions:
Pregnancy Related
Eligibility:
All Genders
18-49 years
Phase:
NA
Brief Summary
The aim of this interventional study is to obtain information about determining the effect of the following drugs. To evaluate prenatal attachment levels and spousal adjustment in couples with fetal h...
Detailed Description
Data will be collected from women who meet the inclusion criteria and agree to participate in the study. Data collection tools will be collected in 2 stages by the researcher using a questionnaire for...
Eligibility Criteria
Inclusion
- Able to communicate,
- Primigravida,
- Over 18 years of age,
- 32 weeks of gestation and above and without any diagnosed risk (such as pre-eclampsia, diabetes, heart disease, placenta previa, oligohydramnios, multiple pregnancy) in the current pregnancy,
- Those who do not have any diagnosed problems related to the health of the fetus (such as fetal anomaly, intrauterine growth retardation) will be included in the study.
Exclusion
- Separated from his wife,
- In the first trimester of pregnancy,
- Those with any diagnosed risk in the mother or baby will not be included in the study.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2024
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT06148415
Start Date
December 1 2023
End Date
March 1 2024
Last Update
October 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inonu University
Malatya, Turkey (Türkiye)